Epilepsy drug and therapy developers at AES 2026
Dec 4–8, 2026 Denver, CO ~6.2k attendees Website
27 epilepsy drug and therapy developers are at AES 2026 — 27 with a booth in the exhibit hall. 27 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–19 of 27 organizations
| Organization | AES 2026 Attendance |
|---|---|
Acadia Pharmaceuticals San Diego, CA | |
Neuroscience biopharma whose approved medicines treat Rett syndrome and Parkinson’s disease psychosis, with a pipeline for other rare neurological diseases. | Booth Exhibiting at Booth 700 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3022 |
Aucta Pharmaceuticals Piscataway, NJ | |
Formulation-focused drug company for CNS disorders; its first branded product is Motpoly XR, a once-daily lacosamide. | Booth Exhibiting at Booth 3603 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Azurity Pharmaceuticals Atlanta, GA | |
Privately held specialty pharmaceutical company making accessible formulations of medicines for underserved patients. | Booth Exhibiting at Booth 3806 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Biocodex Bedminster, NJ | |
U.S. arm of a family-owned French drug company; it markets Diacomit (stiripentol) for seizures in Dravet syndrome. | Booth Exhibiting at Booth 2612 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Biohaven New Haven, CT | |
Biopharma developing neurology medicines, including a Kv7 potassium-channel activator in clinical trials for focal epilepsy. | Booth Exhibiting at Booth 2012 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3124 |
BioMarin Novato, CA | |
Biotechnology company with medicines for rare genetic diseases, including an enzyme replacement therapy for CLN2 Batten disease. | Booth Exhibiting at Booth 3306 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
GRIN Therapeutics New York, NY | |
Develops targeted therapies for pediatric neurodevelopmental disorders driven by NMDA receptor dysfunction, such as GRIN-related disorders. | Booth Exhibiting at Booth 1212 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Harmony Biosciences Plymouth Meeting, PA | |
Develops and markets treatments for rare neurological diseases, with drugs in development for Dravet syndrome and Lennox-Gastaut syndrome. | Booth Exhibiting at Booth 1518 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Immedica Chicago, IL | |
U.S. arm of a Swedish pharmaceutical company that brings medicines for rare diseases to patients. | Booth Exhibiting at Booth 2815 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
J2 Bio-Pharma Las Vegas, NV | |
Privately held specialty pharmaceutical company reformulating neurology medications. | Booth Exhibiting at Booth 2016 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Jazz Pharmaceuticals Palo Alto, CA | |
Global biopharma with medicines for epilepsies, sleep disorders and cancers, including Epidiolex (cannabidiol) for seizures in rare epilepsies. | Booth Exhibiting at Booth 2601 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor offices O3822, O3824, O3922 and O3924 |
Lundbeck Valby, Denmark | |
Danish biopharma focused on brain diseases; its epilepsy pipeline includes bexicaserin for developmental and epileptic encephalopathies. | Booth Exhibiting at Booth 2615 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Neurelis San Diego, CA | |
Neuroscience company whose Valtoco diazepam nasal spray treats seizure clusters. | Booth Exhibiting at Booth 2901 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3122 |
Neurogene New York, NY | |
Clinical-stage company developing gene therapies for rare neurological disorders, including Rett syndrome. | Booth Exhibiting at Booth 805 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Neurona Therapeutics South San Francisco, CA | |
Developing rezanecel, a cell therapy of inhibitory interneurons for drug-resistant focal epilepsy, with a Phase 3 study planned. | Booth Exhibiting at Booth 3315 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Nobelpharma Bethesda, MD | |
U.S. arm of a Japanese company developing medicines for rare diseases, including a sirolimus gel for facial angiofibroma in tuberous sclerosis. | Booth Exhibiting at Booth 1305 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
OWP Pharmaceuticals Naperville, IL | |
U.S. maker of neurology and psychiatry medicines that donates its profits to the ROW Foundation for epilepsy care worldwide. | Booth Exhibiting at Booth 3400, 3500 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Booth Exhibiting at Booth 3404 · OWP Medical Affairs |
Praxis Precision Medicines Boston, MA | |
Clinical-stage biopharma using insights from genetic epilepsies to develop therapies for disorders of brain excitability. | Booth Exhibiting at Booth 1612 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor offices O3422, O3424, O3522 and O3524 |
Rapport Therapeutics Boston, MA | |
Clinical-stage biotech developing precision neuroscience medicines, including RAP-219 for focal epilepsy. | Booth Exhibiting at Booth 605 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Instantly find 20 buyers from epilepsy drug and therapy developers
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AES 2026 by
Organization type
Focus area
- Rare and genetic epilepsies 47
- EEG and monitoring 45
- Patient and family support 32
- Epilepsy medicines 18
- Epilepsy surgery 16
- Software and AI 16
- Clinical trials and registries 14
- Training and certification 9
- Neuromodulation 8
- Genetic testing 7
- Brain mapping and MEG 7
- Gene, cell and RNA therapies 5
- Preclinical research 5
- Wearables and seizure alerts 4
- Careers and recruiting 3
Exhibit hall
Everyone
Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction